You are here

NeonMind Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NEON
CSE Index: 
Currency: 

The Issuer is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness. The Issuer operates three divisions: (i) a pharmaceutical division engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity; and (ii) a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings. 

You are here

NeonMind Biosciences Inc. (NEON)

SEDAR Information

Company Info

Address
Suite 100 - 295 Robinson Street
Oakville, ON L6J 1G7
Canada
Phone
1-212-896-1210
Email
info@neonmind.com
Website
http://www.neonmind.com
Listing date
Tuesday, December 29, 2020
Transfer Agent
Endeavor Trust Corporation
Auditor
Saturna Group Chartered Professional Accountants LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
32,144,142
Reserved for Issuance: 
19,950,250

Bulletins

14/04/2022

2022-0416 – Consolidation - NeonMind Biosciences Inc. (NEON)

le 14 avril/April 2022

NeonMind Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every four (4) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 32,144,140 common shares.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Website_2.jpg

Capital Markets Comeback Tour

Wednesday, May 11, 2022 to Thursday, June 2, 2022
2022-05-25-IR-Summit-Small-Caps_Website.jpg

IR Summit Small Caps

Wednesday, May 25, 2022 -
3:00pm to 4:00pm